CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: 2,5-dihydroxybenzoic acid
Accession: CHEBI:17189
browse the term
Definition: A dihydroxybenzoic acid having the two hydroxy groups at the 2- and 5-positions.
Synonyms: related_synonym: 2,5-Dihydroxybenzoate; 5-hydroxysalicylic acid; Formula=C7H6O4; Gentisate; Gentisic acid; Hydroquinonecarboxylic acid; InChI=1S/C7H6O4/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,8-9H,(H,10,11); InChIKey=WXTMDXOMEHJXQO-UHFFFAOYSA-N; SMILES=OC(=O)c1cc(O)ccc1O
alt_id: CHEBI:11451; CHEBI:19381; CHEBI:19382; CHEBI:936
xref: CAS:490-79-9; Drug_Central:3260; HMDB:HMDB0000152; KEGG:C00628; KNApSAcK:C00002648; LINCS:LSM-19031
xref_mesh: MESH:C010925
xref: MetaCyc:CPD-633; PDBeChem:GTQ; PMID:15862799; PMID:18314336; PMID:22770225; PMID:24547933; Reaxys:2209119; Wikipedia:Gentisic_acid
cyclic_relationship: is_conjugate_acid_of CHEBI:58044
G
Ace
angiotensin I converting enzyme
multiple interactions
ISO
2,5-dihydroxybenzoic acid inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of ACE mRNA]
CTD
PMID:37120126
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Ace2
angiotensin converting enzyme 2
multiple interactions
ISO
2,5-dihydroxybenzoic acid inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of ACE2 mRNA]
CTD
PMID:37120126
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
G
Agtr1a
angiotensin II receptor, type 1a
multiple interactions
ISO
2,5-dihydroxybenzoic acid inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of AGTR1A mRNA]
CTD
PMID:37120126
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
G
App
amyloid beta precursor protein
multiple interactions
ISO
2,5-dihydroxybenzoic acid inhibits the reaction [APP protein modified form binds to APP protein modified form]; Gallic Acid inhibits the reaction [2,5-dihydroxybenzoic acid inhibits the reaction [APP protein modified form binds to APP protein modified form]]
CTD
PMID:22129351
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
G
Cat
catalase
multiple interactions
ISO
2,5-dihydroxybenzoic acid inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased activity of CAT protein]; 2,5-dihydroxybenzoic acid inhibits the reaction [Benzoyl Peroxide results in decreased activity of CAT protein]
CTD
PMID:15454305 PMID:37120126
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cryz
crystallin zeta
multiple interactions
ISO
2,5-dihydroxybenzoic acid inhibits the reaction [Benzoyl Peroxide results in decreased activity of CRYZ protein]
CTD
PMID:15454305
NCBI chr 2:243,552,037...243,580,369
Ensembl chr 2:243,552,119...243,579,758
G
Cybb
cytochrome b-245 beta chain
multiple interactions
ISO
2,5-dihydroxybenzoic acid inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of NOX2 mRNA]
CTD
PMID:37120126
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
G
G6pd
glucose-6-phosphate dehydrogenase
decreases activity multiple interactions
ISO
2,5-dihydroxybenzoic acid results in decreased activity of G6PD protein mutant form 2,5-dihydroxybenzoic acid inhibits the reaction [Benzoyl Peroxide results in decreased activity of G6PD protein]
CTD
PMID:5432368 PMID:15454305
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
G
Gsr
glutathione-disulfide reductase
multiple interactions
ISO
2,5-dihydroxybenzoic acid inhibits the reaction [Benzoyl Peroxide results in decreased activity of GSR protein]
CTD
PMID:15454305
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Il10
interleukin 10
multiple interactions
ISO
2,5-dihydroxybenzoic acid inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of IL10 mRNA]; 2,5-dihydroxybenzoic acid inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of IL10 protein]
CTD
PMID:37120126
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Keap1
Kelch-like ECH-associated protein 1
multiple interactions
ISO
2,5-dihydroxybenzoic acid promotes the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of KEAP1 mRNA]
CTD
PMID:37120126
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
G
Mir200a
microRNA 200a
multiple interactions
ISO
2,5-dihydroxybenzoic acid promotes the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of MIR200A]
CTD
PMID:37120126
NCBI chr 5:166,648,494...166,648,582
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions
ISO
2,5-dihydroxybenzoic acid promotes the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of NFE2L2 protein]
CTD
PMID:37120126
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions
ISO
2,5-dihydroxybenzoic acid promotes the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of NQO1 mRNA]
CTD
PMID:37120126
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Odc1
ornithine decarboxylase 1
multiple interactions
ISO
2,5-dihydroxybenzoic acid inhibits the reaction [Benzoyl Peroxide results in increased activity of ODC1 protein]
CTD
PMID:15454305
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
2,5-dihydroxybenzoic acid inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased phosphorylation of RELA protein]
CTD
PMID:37120126
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Sod1
superoxide dismutase 1
multiple interactions
ISO
2,5-dihydroxybenzoic acid inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased activity of SOD1 protein]
CTD
PMID:37120126
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sult1a1
sulfotransferase family 1A member 1
increases activity increases expression
ISO EXP
2,5-dihydroxybenzoic acid results in increased activity of SULT1A1 protein 2,5-dihydroxybenzoic acid results in increased expression of SULT1A1 mRNA
CTD
PMID:16308312 PMID:16443358
NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:181,272,023...181,275,562
G
Sult2a1
sulfotransferase family 2A member 1
increases expression
EXP
2,5-dihydroxybenzoic acid results in increased expression of SULT2A1 mRNA
CTD
PMID:16443358
NCBI chr 1:75,451,178...75,508,113
Ensembl chr 1:74,911,100...75,508,134
G
Tgfb1
transforming growth factor, beta 1
multiple interactions
ISO
2,5-dihydroxybenzoic acid inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of TGFB1 mRNA]; 2,5-dihydroxybenzoic acid inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of TGFB1 protein]
CTD
PMID:37120126
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tnf
tumor necrosis factor
multiple interactions
ISO
2,5-dihydroxybenzoic acid inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of TNF mRNA]; 2,5-dihydroxybenzoic acid inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of TNF protein]
CTD
PMID:37120126
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
CHEBI ontology
19911
role
19854
application
19722
MALDI matrix material
1046
2,5-dihydroxybenzoic acid
21
2,5-dihydroxybenzoic acid 2-O-beta-D-glucoside
0
2,5-dihydroxybenzoic acid 5-O-beta-D-glucoside
0
2,5-dihydroxybenzoyl-CoA
0
benzyl 2,5-dihydroxybenzoate
0
mygalin
0
Path 2
CHEBI ontology
19911
subatomic particle
19909
composite particle
19909
hadron
19880
baryon
19880
nucleon
19909
atomic nucleus
19880
atom
19909
main group element atom
19849
p-block element atom
19849
carbon group element atom
19766
carbon atom
19785
organic molecular entity
19785
heteroorganic entity
19541
organochalcogen compound
19301
organooxygen compound
19193
carbon oxoacid
18681
carboxylic acid
18678
aromatic carboxylic acid
12711
benzoic acids
12688
benzoic acid
5505
hydroxybenzoic acid
4981
dihydroxybenzoic acid
83
2,5-dihydroxybenzoic acid
21
2,5-dihydroxybenzoic acid 2-O-beta-D-glucoside
0
2,5-dihydroxybenzoic acid 5-O-beta-D-glucoside
0
2,5-dihydroxybenzoyl-CoA
0
benzyl 2,5-dihydroxybenzoate
0
mygalin
0